What are the risks of investing in MDXG?
M
What are the risks of investing in MDXG?
🦉
MiMedx Group, Inc. (MDXG)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOJoseph H. Capper
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory...
Key Executives
| Name | Title |
|---|---|
| David H. Mason Jr. | Chief Medical Officer |
| Douglas C. Rice | Chief Financial Officer |
| Eric A. Smith | Senior VP of Marketing & International |
| Hilary Dixon | Vice President of Investor Relations & Corporate Strategic Communications |
| John Harper | SVP of R&D & Medical Affairs and Chief Scientific Officer |
| Joseph H. Capper | Chief Executive Officer & Director |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A